Ibalizumab

Modify Date: 2024-01-05 13:12:35

Ibalizumab Structure
Ibalizumab structure
Common Name Ibalizumab
CAS Number 680188-33-4 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Ibalizumab


Ibalizumab (TMB-355) is a humanised IgG4 monoclonal antibody that prevents HIV cell entry by binding to CD4 receptor. Ibalizumab has the potential for HIV-1 infection research[1].

 Names

Name Ibalizumab

 Ibalizumab Biological Activity

Description Ibalizumab (TMB-355) is a humanised IgG4 monoclonal antibody that prevents HIV cell entry by binding to CD4 receptor. Ibalizumab has the potential for HIV-1 infection research[1].
Related Catalog
Target

HIV-1

References

[1]. Anthony Markham. Ibalizumab: First Global Approval. Drugs. 2018 May;78(7):781-785.

 Chemical & Physical Properties

No Any Chemical & Physical Properties